Delivery Order SPE2DB20D1004-SPE2DB25FNJPM
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,592.90 for NovoLog 100 Unit/mL vials (10 mL) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,749.33 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions. The contract calls for performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $9,353.44 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The delivery order, which represents a non-competitive set-aside award, is scheduled for completion by July 22, 2025, with performance occurring at the vendor's Conshohocken facility. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,045.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) to be delivered by July 29, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL units). This is a firm fixed price, competitive delivery order with no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $4,385.18 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.84 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 unit/mL vials (10 mL) under a firm fixed-price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting the federal...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $453.80 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 units of Novolog insulin per milliliter in 10 milliliter vials. Performance will take place in Conshohocken, Pennsylvania over a three day period from July 7-10, 2023. The delivery order was issued under DLA Troop Support Medical's indefinite-delivery/indefinite-quantity pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $3,648.07. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $6,072.14. This is a firm fixed-price delivery order issued without set-aside provisions, indicating competitive award to a qualified vendor. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJPMDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,809.62 by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Novolog 100 Unit/mL vials (10mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to the Conshohocken, PA location. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. The DLA Troop Support Medical Supply Chain regularly issues delivery orders for critical medications including diabetes treatments, neurological therapies, and other specialty pharmaceuticals to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive award processes and maintains a diverse portfolio of pharmaceutical deliveries ranging from routine to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/23/25 |